More than one pathway: novel treatment for ITP.
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2018-12-892778
Abstract: In this issue of Blood, Zhao et al explored the role of low doses of the histone deacetylase inhibitor (HDACi) chidamide in restoring immune tolerance in patients with immune thrombocytopenia (ITP).1 read more here.
Keywords: pathway novel; treatment itp; novel treatment; one pathway ... See more keywords